QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Esmail, Hanif ^a,b,c   Thienemann, Friedrich ^a   Oni, Tolu ^a   Goliath, Rene ^a   Wilkinson, Katalin A ^a,d   Wilkinson, Robert J ^a,b,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

Diagnostics; HIV; Interferon Gamma Release Assay; Latent tuberculosis; QuantiFERON TB Gold in tube

Indexed keywords

BACTERIAL ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PROCEDURES; MICROBIOLOGY; PROCEDURES; SOUTH AFRICA; TUBERCULOSIS; VIROLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC TESTS; LATENT TUBERCULOSIS; MALE; ROC CURVE; SOUTH AFRICA; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84990861481     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1875-6     Document Type: Article

References (15)

1. Esmail H, Barry 3rd CE, Wilkinson RJ. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies. Drug Discov Today. 2012;17:514-21.
2. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med. 2010;207:2869-81.
3. ATS/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1-5.
4. Hecker MT, Johnson JL, Whalen CC, Nyole S, Mugerwa RD, et al. Two-step tuberculin skin testing in HIV-infected persons in Uganda. Am J Respir Crit Care Med. 1997;155:81-6.
5. Santin M, Munoz L, Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS ONE. 2012;7:e32482.
6. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis. 2011;204 Suppl 4:S1120-9.
7. van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, et al. Within-subject variability and boosting of T cell IFN-{gamma} responses following tuberculin skin testing. Am J Respir Crit Care Med. 2009;180:49-58.
8. Sauzullo I, Massetti AP, Mengoni F, Rossi R, Lichtner M, et al. Influence of previous tuberculin skin test on serial IFN-gamma release assays. Tuberculosis. 2011;91:322-6.
9. Ritz N, Yau C, Connell TG, Tebruegge M, Leslie D, et al. Absence of interferon-gamma release assay conversion following tuberculin skin testing. Int J Tuberc Lung Dis. 2011;15:767-9.
10. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, et al. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest. 2008;133:1415-20.
11. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, et al. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189:77-87.
12. Ndiaye BP, Thienemann F, Ota M, Landry BS, Camara M, et al. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2015;3:190-200.
13. Wood R, Liang H, Wu H, Middelkoop K, Oni T, et al. Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis. 2010;14:406-12.
14. Baker CA, Thomas W, Stauffer WM, Peterson PK, Tsukayama DT. Serial testing of refugees for latent tuberculosis using the QuantiFERON-gold in-tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg. 2009;80:628-33.
15. Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, et al. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis. 2009;9:182.